Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States

Parkinsonism and Related Disorders

Volumn 19, Issue 2, 2013, Pages 202-206

  Willis, A W ^a   Schootman, M ^a   Kung, N ^a   Racette, B A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Dementia; Medicare; Psychiatry; Young Onset Parkinson's Disease

Indexed keywords

ADDICTION; ADULT; AMERICAN INDIAN; ARTICLE; ASIAN; CAUCASIAN; CLINICAL FEATURE; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DISABILITY SEVERITY; DISEASE SURVEILLANCE; FEMALE; HISPANIC; HUMAN; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICARE; MENTAL DISEASE; NEGRO; NEUROPSYCHIATRY; ONSET AGE; PARKINSON DISEASE; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOSOCIAL DISORDER; RACE DIFFERENCE; SEX DIFFERENCE; UNITED STATES;

ADULT; AGE OF ONSET; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; UNITED STATES;

EID: 84873736288     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.09.014     Document Type: Article

References (28)

1. Wright W.A., Evanoff B.A., Lian M., Criswell S.R., Racette B.A. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology 2010, 34:143-151.
2. Schrag A., Hovris A., Morley D., Quinn N., Jahanshahi M. Young- versus older-onset Parkinson's disease: impact of disease and psychosocial consequences. Mov Disord 2003, 18:1250-1256.
3. Wickremaratchi M.M., Knipe M.D., Sastry B.S., Morgan E., Jones A., Salmon R., et al. The motor phenotype of Parkinson's disease in relation to age at onset. Mov Disord 2011, 26:457-463.
4. Schrag A., Ben-Shlomo Y., Brown R., Marsden C.D., Quinn N. Young-onset Parkinson's disease revisited - clinical features, natural history, and mortality. Mov Disord 1998, 13:885-894.
5. Calne S.M., Kumar A. Young onset Parkinson's disease. Practical management of medical issues. Parkinsonism Relat Disord 2008, 14:133-142.
6. Lucking C.B., Durr A., Bonifati V., Vaughan J., De M.G., Gasser T., et al. Association between early-onset Parkinson's disease and mutations in the Parkin gene. N Engl J Med 2000, 342:1560-1567.
7. Muangpaisan W., Mathews A., Hori H., Seidel D. A systematic review of the worldwide prevalence and incidence of Parkinson's disease. J Med Assoc Thai 2011, 94:749-755.
8. Schrag A., Ben-Shlomo Y., Quinn N.P. Cross sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ 2000, 321:21-22.
9. Wickremaratchi M.M., Perera D., O'Loghlen C., Sastry D., Morgan E., Jones A., et al. Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatr 2009, 80:805-807.
10. Muangpaisan W., Hori H., Brayne C. Systematic review of the prevalence and incidence of Parkinson's disease in Asia. J Epidemiol 2009, 19:281-293.
11. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 2006, 248:151-157.
12. Shulman L.M., Taback R.L., Bean J., Weiner W.J. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001, 16:507-510.
13. Voon V., Hassan K., Zurowski M., Duff-Canning S., de S.M., Fox S., et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 2006, 66:1750-1752.
14. Weintraub D., Koester J., Potenza M.N., Siderowf A.D., Stacy M., Voon V., et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010, 67:589-595.
15. Katzen H.L., Levin B.E., Llabre M.L. Age of disease onset influences cognition in Parkinson's disease. J Int Neuropsychol Soc 1998, 4:285-290.
16. Mayeux R., Denaro J., Hemenegildo N., Marder K., Tang M.X., Cote L.J., et al. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 1992, 49:492-497.
17. Paviour D.C., Surtees R.A., Lees A.J. Diagnostic considerations in juvenile parkinsonism. Mov Disord 2004, 19:123-135.
18. CMS chronic condition data warehouse condition categories 2011, Centers for Medicare and Medicaid Services, [cited 2011 Sep 8]; Available from:. http://www.ccwdata.org/cs/groups/public/documents/document/ccw_conditioncategories.pdf.
19. Centers for medicare and medicaid services 2011, Data Dictionairies-CCW Chronic Condition Warhouse.
20. Willis A.W., Schootman M., Kung N., Evanoff B.A., Perlmutter J.S., Racette B.A. Predictors of survival in patients with Parkinson disease. Arch Neurol 2012 Jan 2, [Epub ahead of print].
21. Wickremaratchi M.M., Ben-Shlomo Y., Morris H.R. The effect of onset age on the clinical features of Parkinson's disease. Eur J Neurol 2009, 16:450-456.
22. Aarsland D., Marsh L., Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 2009, 24:2175-2186.
23. Gschwandtner U., Aston J., Renaud S., Fuhr P. Pathologic gambling in patients with Parkinson's disease. Clin Neuropharmacol 2001, 24.
24. Shiba M., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000, 15:669-677.
25. Bower J.H., Grossardt B.R., Maraganore D.M., Ahlskog J.E., Colligan R.C., Geda Y.E., et al. Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord 2010, 25:2105-2113.
26. Remy P., Doder M., Lees A., Turjanski N., Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005, 128:1314-1322.
27. Schneier F.R., Liebowitz M.R., Abi-Dargham A., Zea-Ponce Y., Lin S.H., Laruelle M. Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry 2000, 157:457-459.
28. Knipe M.D., Wickremaratchi M.M., Wyatt-Haines E., Morris H.R., Ben-Shlomo Y. Quality of life in young-compared with late-onset Parkinson's disease. Mov Disord 2011, 26:2011-2018.